Showing results (131-140 of 276) with videos related to

Sort By:
Pageof 28
Arthritis Research & Therapy|December 17, 2005
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective studyFabiola Atzeni, Piercarlo Sarzi-Puttini, Donata Dell' Acqua, et al.
British Journal of Haematology|June 29, 2005
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammationMassimo Cugno, Piergiuseppe Agostoni, Daniela Mari, et al.
Journal of Clinical Medicine|July 12, 2020
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot StudyDaniela Greco, Roberta Gualtierotti, Pasquale Agosti, et al.
Frontiers in Immunology|February 13, 2016
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus ErythematosusMaria Gerosa, Barbara Poletti, Francesca Pregnolato, et al.
Arthritis Research & Therapy|November 10, 2020
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosisElena Raschi, Daniela Privitera, Caterina Bodio, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 25, 2011
Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid AntibodiesSilvia S Pierangeli, Emmanuel J Favaloro, Gabriella Lakos, et al.
Arthritis Care & Research|April 15, 2010
Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic diseaseIvana Hollan, Barbara Bottazzi, Ivan Cuccovillo, et al.
Rheumatology (Oxford, England)|October 6, 2018
Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert ConsensusAlessandra Bortoluzzi, Guido Valesini, Salvatore D'Angelo, et al.
Autoimmunity Reviews|September 15, 2007
AutoAbSC.Org -- Autoantibody Standardization Committee in 2006Edward K L Chan, Marvin J Fritzler, Allan Wiik, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritisGabriella Moroni, Donatella Ventura, Paola Riva, et al.
Pageof 28